Search
Filters
Clear All
  • 4

Phase

  • 1
  • 3
  • 2
  • 2

Found 4 James Chmiel trials

A listing of James Chmiel medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!

HAVE YOU RECENTLY TESTED POSITIVE FOR COVID? Help Us Test a New Treatment for Covid!

J
James Chmiel
M
Mike Davis
18 years - 60 years
Accepts healthy volunteer
All genders
Researchers at Indiana University School of Medicine are researching a nasal treatment for COVID-19. We are looking for people with a recent onset of mild COVID-19 symptoms and a positive COVID-19 test in the last few days to come for a 2 hour visit at Riley Hospital for Children to help …
Check Eligibility

A Prospective Study to Evaluate Biological and Clinical Effects of Significantly Corrected CFTR Function in Infants and Young Children (BEGIN)

J
James Chmiel
5 years or below
All genders
This is a two-part, multi-center, prospective longitudinal, exploratory study of highly effective cystic fibrosis transmembrane conductance regulator (CFTR) modulators and their impact in children with cystic fibrosis (CF) on endocrine growth factors and height, gastrointestinal function and gut microbiome, lung function and respiratory microbiome, liver and pancreatic function, sweat chloride, …
Learn More
Volunteers with ASTHMA or CYSTIC FIBROSIS Needed for Human Airway Study

Volunteers with ASTHMA or CYSTIC FIBROSIS Needed for Human Airway Study

J
James Chmiel
18 years - 50 years
Accepts healthy volunteer
All genders
You have probably heard about the pH levels of soils – if it is acidic or basic. Did you know that the human airway also has a measurement of its acidity and basicity, called airway pH? Researchers at Indiana University School of Medicine are researching how to identify the airway …
Check Eligibility

Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age

J
James Chmiel
1 year - 11 years
All genders
Phase 3
Interventional
The purpose of this study is to evaluate the pharmacokinetics, safety, tolerability andy of VX-121/tezacaftor/deutivacaftor (VX-121/TEZ/D-IVA) in CF participants with at1 triple combination responsive (TCR) mutation in the cystic fibrosis transmembraneductance regulator (CFTR) gene.
Learn More